A suivre (test sur 15,000 participants, avec un taux de réussite de 90%).
Je cite:
"The test exploits the fact that cancers are abnormally methylated, and ... that different cancers have different methylation patterns," study co-author Eric Klein from the Cleveland Clinic in Ohio, tells Chemistry World.
Overall, the test accurately predicted the location where the cancer began more than 90% of the time, and only wrongly indicated the presence of cancer 0.7 percent of the time.
